The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing ...
Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...
Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...
An international study identifies distinct gut microbiota linked to interstitial lung disease in systemic sclerosis, ...
Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...
Please provide your email address to receive an email when new articles are posted on . HUNTINGTON BEACH, Calif. — Better diagnostics and more treatment options have modestly improved interstitial ...
In a first-of-its-kind regional milestone, the Abu Dhabi Stem Cells Center (ADSCC), in collaboration with Yas Clinic Khalifa ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease associated with poor quality of ...
We understand who Murugan is, why he holds his forest so close, the crushing reason behind his decision to join ISGS, and the long journey he has reached a midpoint in. A new terrain and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback